top of page

Who we are

Novocuff, Inc. is a medical device company dedicated to improving outcomes for pregnancies affected by preterm premature rupture of membranes (PPROM) or cervical shortening.   

Why it matters

​PPROM is defined as the amniotic sac breaking and leaking before 37 weeks of pregnancy. Management of PPROM is influenced by gestational age and the presence of maternal and fetal complicating factors/ and always results in preterm birth. According to the American College of Obstetrics and Gynecology (ACOG), PPROM complicates approximately 2-3% of all pregnancies in the United States and represents a significant proportion of preterm births.1
 
Cervical insufficiency is when the cervix is unable to sustain a pregnancy to term.2  Cervical shortening may be identified in the second or early third trimester of an ongoing pregnancy. Progressive cervical dilation at an early gestational age can result in PPROM, pregnancy loss, or spontaneous preterm birth.3
 
Preterm birth is the leading cause of death for infants under the age of one. According to the World Health Organization (WHO), preterm birth complications were responsible for approximately 1 million deaths in 2020.4
 

References
 

  1. ACOG Practice Bulletin No. 217. Prelabor Rupture of Membranes. American College of Obstetricians and Gynecologists. March 2020 - Volume 135, No. 3: - e80-97

  2. American College of Obstericians and Gynecologists. ACOG Practice Bulletin. Cervical insufficiency. Obstet Gynecol. 2003 Nov;102(5 Pt 1):1091-9. doi: 10.1016/j.obstetgynecol.2003.09.029. PMID: 14672493.

  3. Thakur M, Jenkins SM, Mahajan K. Cervical Insufficiency. [Updated 2024 Oct 6]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2024 Jan-. Available from: https://www.ncbi.nlm.nih.gov/books/NBK525954/

  4. World Health Organization (2023 May 10), Preterm Birth, https://www.who.int/news-room/fact-sheets/detail/preterm-birth

team

Team

Headshot 2.png

Amelia Degenkolb
CEO & Co-Founder

Lisa Tehrani - 1 - cropped on white.jpg

Lisa Tehrani 
Director of Marketing

Donald Lee
COO & Co-Founder

Marissa DSC07239d.jpg

Marissa VanDeVeer
Clinical Engineer

Kathryn Wine
VP of Clinical Affairs

Cindy Domecus headshot_Oct 2024.jpg

Cindy Domecus
Regulatory Affairs

Debra Snowdale.jpg

Debra Snowdale
CFO

technology

Our device

Novocuff has designed a medical device that aims to address the complex conditions of PPROM and short cervix. The Novocuff Cervical Control System (CCS) has been designed with the goal of supporting and closing the cervix to retain amniotic fluid in patients with PPROM and sustain cervical length in patients with cervical shortening, with the aim of extending pregnancy and reducing the degree of prematurity. 
 


CAUTION - Investigational device. Limited by United States law to investigational use.
 

news

News

Expecting the Unexpected

Novocuff Joins FI to Help Prevent Preterm Birth

Spotlight: Amelia (Amy) Degenkolb, Ferolyn Fellow

contact us

contact us

Thank you! We'll get back to you asap!

Copyright © 2025 Novocuff

bottom of page